Actors and Networks database
The evolving field of gene and cell therapy is supported by a large community of academic, clinical, translational, regulatory and patient organisations. The Actors and Networks database maps these stakeholders in Europe and beyond, their activities, and resources they have produced.
EuroGCT has developed and compiled this database for those interested in identifying the actors involved at each stage of the pathways bringing gene and cell therapies from lab to clinic. Coming from an academic perspective, our focus is to map information that has not been mapped elsewhere. This includes documenting the various types of interconnected regulators, patient groups actively involved along the pathways, and non-profit organisations devoted to therapy development. In its first iteration, this database does not yet include commercial partners and service providers.
Additional complementary work by other organisations on GCT stakeholders mapping can be found here.
German Stem Cell Network (GSCN)
Additional information
The German Stem Cell Network (GSCN) aims at creating synergies between all areas of basic and applied stem cell research and to provide an interface between science, education, politics and society as a whole. The central task of the GSCN is to pool the expertise in stem cell research in Germany and develop synergies between basic research, regenerative medicine and pharmacology. The initiative promotes innovative research activities on a national and international level. In addition, targeted information and events are offered to encourage the public discourse on stem cell research. Since 1 January 2021 the GSCN works in a tight cooperation with the Berlin Institute of Health (BIH). The GSCN and the BIH have formed a "Dialog Platform Stem Cell Research" as a project to foster stem cell research as basic science and in the translation.
Haute Autorité de santé (HAS)
Additional information
The Haute Autorité de santé (HAS) or French National Authority for Health brings together under a single roof a number of activities designed to improve the quality of patient care and to guarantee equity within the healthcare system. They range from assessment of drugs, medical devices, and procedures to publication of guidelines to accreditation of healthcare organisations and certification of doctors.
Institut national de la santé et de la recherche médicale (National Institute for Health and Medical Research) (Inserm)
Institut national du cancer (National Institue for Cancer) (Inca)
International Patient Organisation for Primary Immunodeficiency (IPOPI)
Additional information
IPOPI is a non-profit international organisation and the leading advocate for primary immunodeficiency (PID) patients worldwide working in collaboration with patients, doctors, politicians, regulators, pharmaceutical industry and other relevant stakeholders.
Karolinska Institutet (KI)
Additional information
KI is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences.
Medical Device Coordination Group Working Groups (MDCG)
Ministère chargé de l’enseignement supérieur et de la recherche
Additional information
The Ministry of Higher Education and Research receives declarations of preservation and preparation for scientific purposes of tissues and cells from the human body for the needs of research programmes, as well as requests for authorisation for preservation and preparation with a view to their transfer for scientific use. In addition, any contained use of Genetically Modified Organism is subject to a request for authorisation or a declaration to the Ministry. Finally, the Ministry receives applications for authorisation to import/export human body parts and products for scientific purposes.